A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Geneva Finance Committee rejects budget
It looks like Geneva won’t have a budget for next year.
Initiative planned for airline tax
A citizens’ initiative to curb air traffic growth and boost public transport is being prepared for next year.
Births hit an all-time low
Switzerland’s birth rate has reached a historic low. New figures from the Federal Statistical Office show women had an average of just 1.29 children in 2024 — the lowest level ever recorded.
Christmas on the Quai starts next week
Christmas on the Quai returns to Geneva’s Quai du Mont-Blanc from November 20th to December 24th.
Steve Jobs's family came from Switzerland
It turns out Apple co-founder Steve Jobs had Swiss roots.
Is a Trump deal close?
The financial news service Bloomberg says that Switzerland is in the verge of a new trade deal with the United States.
